Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
1,993 recalls · newest first
Superpotent Drug
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established…
CGMP Deviations: sterile water not used for production
Lack of Assurance of Sterility
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
Failed Dissolution Specifications: below specification results
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Presence of Particulate Matter
Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
CGMP Deviations
Defective container; yellow colored spike from cap lodged in the nozzle
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg.
Failed Dissolution Specifications
Subpotent Drug: reduced efficacy for epinephrine
Cross contamination with other products.
Defective container: potential for non-sealed pouches which can lead to product leakage.
Cross contamination with other products.
Cross contamination with other products
Cross contamination with other products